Please login to the form below

Not currently logged in
Email:
Password:

Abraxane

This page shows the latest Abraxane news and features for those working in and with pharma, biotech and healthcare.

New data could put Roche’s Tecentriq first in squamous lung cancer

New data could put Roche’s Tecentriq first in squamous lung cancer

The phase III IMpower131 study showed that adding the PD-L1 inhibitor to standard first-line chemotherapy with carboplatin and Celgene’s Abraxane (nab-paclitaxel) in patients with advanced squamous

Latest news

More from news
Approximately 15 fully matching, plus 29 partially matching documents found.

Latest from PMHub

  • Marketing strategy in complex environments

    cells. A good example of this is the combined use of  Abraxane and  gemcitabine in the treatment of  metastatic adenocarcinoma of the pancreas – Abraxane helps to inhibit cancer cell growth, and

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics